Stanford Medicine
Avatar

COVID-19, Insulin Dosing & Therapeutic Inertia: Why Is it so Hard for Patients to Start Taking Insulin? How Can We Overcome Therapeutic Inertia?

By Stanford Medicine FEATURING Jay Shubrook
August 25, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
06:38
Emory Diabetes Education Training Academy

In-Hospital Management of Diabetes: What Is the Efficacy of Basal Plus Cor…

Feat. G. Umpierrez
20:56
Stanford Medicine

COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer Outcomes i…

Feat. A. Peters
18:13
Stanford Medicine

Diabetes & COVID-19: What Are the Requirements of Complex Diabetes Treatme…

Feat. N. Cuttriss
14:47
Stanford Medicine

COVID-19, Insulin Dosing & Therapeutic Inertia: What to Do After Basal Ins…

Feat. J. Shubrook
13:18
Northwestern Medicine Endocrinology

Obesity & COVID-19: What Is the Role of Obesity in Developing Severe Sym...

Feat. R. Kushner
13:36
Stanford Medicine

COVID-19: Are Patients With Diabetes More Prone to Get Infected? Should ...

Feat. R. Lal, N. Cuttriss, M. Bouchonville
23:36
Jay Shubrook

Insulin Dose Changes in the Time of COVID-19: What are the ADA Recommended…

03:05
Stanford Medicine

Diabetes and COVID-19: Can Depression Affect or Worsen Diabetes Control ...

Feat. J. Wong
09:51
Stanford Medicine

COVID-19 & Strategies to Improve Care for High-Risk Patients With Type 2 D…

Feat. J. Kennedy
27:27
Stanford Medicine

Diabetes Patient Needs During COVID-19: How Important is the Power of th...

Feat. K. Close
25:28
Stanford Medicine

COVID-19 & Diabetes Patient Needs: Does Everyone With Diabetes Need to H...

Feat. K. Close
06:27
Stanford Medicine

Diabetes Care During COVID-19 Pandemic: How to Remotely Monitor Patients...

Feat. N. Cuttriss
11:41
Stanford Medicine

COVID-19 & Telehealth Practical Tips: How to Prioritize Essential Compon...

Feat. N. Cuttriss
17:21
Ilene Fennoy

Obesity and Diabetes in Children

31:39
Cardiovascular Disease Management - 4th Annual Symposium

Diabetes: An Epidemic - Panel Discussion / Q & A

Feat. R. Heuser, G. Adams
14:07
Richard Pratley

Updates from LEADER (liraglutide) and DEVOTE (degludec) Trials

15:33
Cardiometabolic Health Congress (CMHC)

Case Presentation 64 Year Old Type 2 Diabetes and Discussion

Feat. W. Lane
15:28
Benjamin Nwosu

Pediatric Diabetes Mellitus: Partial Clinical Remission and its Clinical...

06:22
Cardiometabolic Health Congress (CMHC)

Converting to New Basal Insulins and Combination Therapies with Insulin

Feat. A. Peters
07:11
Cardiometabolic Health Congress (CMHC)

Optimizing Insulin Therapy in Type 2 Diabetes

Feat. D. Wexler